Microbial Chemotherapy I

Introduction to Infectious Disease Treatment

• Overview of the presentation goals and structure

  • The goal is to provide an understanding of how to treat infectious diseases effectively. It is structured in two parts to make it easier to digest the information.

Objectives of the Presentation

• Drug Use in Infections

  • Drugs play a crucial role in both preventing and treating infections. Understanding when to use these drugs is essential for effective healthcare.

• Microbial Physiology

  • Microbial physiology refers to the functions and structures of microbes, such as bacteria, viruses, and fungi. Knowledge of these aspects helps in creating drugs that target microbes specifically and minimize harm to human cells.

• Drug Properties

  • The effectiveness of a drug depends on its pharmacokinetic (how the body processes the drug) and pharmacodynamic (how the drug affects the body) properties. These properties are essential for choosing the right medication for treating infections.

• Physiological Differences in Bacteria

  • Bacteria can be classified based on their structures:

    • Gram positive: These bacteria have a thick outer wall that can easily be targeted by certain antibiotics.

    • Gram negative: These bacteria have an additional outer membrane that makes them generally harder to treat with certain drugs.

    • Mycobacteria: This type of bacteria has a unique cell wall that prevents many antibiotics from working, requiring specialized treatment.

• Adverse Effects of Antimicrobial Drugs

  • Antimicrobial drugs can have side effects that vary from mild to severe. Understanding these is vital for managing patient treatment effectively.

• Bactericidal vs. Bacteriostatic

  • This distinction affects how drugs work:

    • Bactericidal: These drugs kill bacteria outright.

    • Bacteriostatic: These drugs inhibit the growth of bacteria, allowing the immune system to eliminate the pathogens.

Reasons for Using Antimicrobial Drugs

• Treating Active Infections

  • The primary goal of antimicrobial drugs is to treat active infections in patients to help them recover more quickly.

• Prophylaxis

  • In some cases, drugs are used to prevent infections before they occur. Examples include:

    • Chloroquine: Taken to prevent malaria when traveling to areas where it's common.

    • Preventive treatment for tuberculosis: Given to individuals in close contact with infected persons to lower the risk of developing the disease.

Concept of Selective Targeting in Antimicrobial Treatment

• Paul Ehrlich's Magic Bullet Concept

  • This concept refers to the idea that drugs should be able to specifically target microbes without affecting human cells, similar to how a bullet targets a specific target without collateral damage.

• Categories of Infectious Diseases

  • Infectious diseases can be bacterial, fungal, viral, or parasitic, each requiring different strategies for treatment.

Targeting Bacteria

• Unique Cell Wall Structures

  • Bacterial cell walls are different from human cell structures, providing an opportunity for drugs to target these areas without harming human cells.

• Protein Synthesis

  • Bacteria have unique machinery for protein synthesis. Drugs can target this machinery, which is structurally different from that of human cells.

• DNA and RNA Synthesis

  • The differences in the way bacteria synthesize their genetic material allow for selective targeting by specific drugs.

Targeting Fungi

• Fungal Cell Wall

  • The cell wall of fungi differs significantly from bacteria, which means drugs that work against bacteria may not be effective against fungi.

• Ergosterol in Membrane

  • Fungi have a component in their cell membranes called ergosterol, which is absent in human cells. Targeting ergosterol can effectively kill fungal cells.

Targeting Viruses

• Use of Host Machinery

  • Viruses rely on the host's cellular machinery to replicate, which makes targeting them more challenging. Drugs must be designed to intercept these processes without harming the host.

• Viral Specific Proteins

  • Certain drugs can target proteins that are involved in the virus's replication cycle, such as those involved in synthesizing DNA or RNA and assembling new viral particles.

Targeting Parasitic Infections

• Unique Physiological Attributes

  • Parasites, such as protozoans and worms, have unique structures and life cycles that offer various potential targets for drug treatments.

Need for Diverse Antimicrobial Drugs

• Spectrum of Action

  • Different antimicrobial drugs are designed to treat specific types of pathogens, such as bacteria, fungi, or viruses, which is important for effective treatment.

• Resistance Development

  • Over time, some pathogens become resistant to existing drugs, highlighting the constant need for new medications to combat these evolving threats.

• Pharmacokinetic Properties

  • It's crucial for drugs to be effective in various body compartments. For example:

    • Drugs need to penetrate the central nervous system effectively when treating conditions like meningitis.

    • Other infections may require drugs to target intracellular spaces, where pathogens can reside.

• Minimizing Adverse Effects

  • New drug development aims to reduce side effects, making treatments safer for patients.

• Drug-Drug Interactions

  • When multiple medications are used, it's important to consider how they may interact with one another, as these interactions can affect both safety and effectiveness.

Selecting Appropriate Drugs for Treatment

• Fit the Drug to the Bug

  • Choosing the right drug is essential for effectively treating different pathogens. This involves understanding:

    • Antibacterials: target bacterial infections.

    • Antifungals: used for fungal infections.

    • Antivirals: combat viral infections.

    • Antiparasitics: treat parasitic infections.

Classification of Bacteria

• Gram Positive vs. Gram Negative Bacteria

  • Gram Positive:

    • Have a thick peptidoglycan cell wall that can be easily targeted with certain antibiotics, such as penicillin.

  • Gram Negative:

    • Characterized by an outer membrane, requiring drugs to penetrate this structure before accessing the bacterial cell wall and its targets.

• Mycobacteria

  • This group contains bacteria with a unique cell wall made of mycolic acid, rendering many traditional antibiotics ineffective. Specific treatments are necessary for these infections.

• Mycoplasma

  • These bacteria lack a cell wall, which requires different treatment strategies, as conventional cell wall-targeting antibiotics won’t work.

Bacterial Respiration and Drug Selection

• Aerobic vs. Anaerobic Respiration

  • Different pathogens may rely on oxygen for energy (aerobic) or can thrive without it (anaerobic), which influences treatment options.

• Intracellular Pathogens

  • Some pathogens, like chlamydia and mycobacteria, live inside human cells and require drugs that can reach these internal environments to be effective.

Adverse Effects of Antimicrobial Drugs

• Hypersensitivity Reactions

  • Some individuals may experience allergic reactions to certain drugs, such as penicillin, making it crucial for healthcare providers to be aware of patients' histories.

• Superinfection

  • Sometimes antibiotics can disrupt the normal bacterial flora in the body, leading to other infections. For instance, treatments can result in conditions like:

    • Pseudomembranous Colitis caused by Clostridium difficile.

    • Candidiasis, an overgrowth of Candida albicans.

• Organ-Specific Toxicities

  • Some drugs can cause specific damage to organs, such as the kidneys or liver, so monitoring for these side effects is essential during treatment.

Drug-Drug Interactions

• Considering the interactions between multiple drugs is vital. These interactions may alter the effectiveness of treatments or increase the risk of side effects, affecting a patient's recovery and health outcomes.

Bactericidal vs. Bacteriostatic Drugs

• Definitions

  • Bacteriostatic drugs: Help stop bacteria from multiplying, allowing the immune system to do the work of killing off the bacteria.

  • Bactericidal drugs: Directly kill the bacteria, making them essential in critical situations where the body’s immune response may be insufficient.

• Clinical Relevance

  • Bacteriostatic drugs are often sufficient for healthy patients, while bactericidal drugs are preferred for patients with weak immune systems or severe infections requiring rapid action, such as in cases of meningitis or endocarditis.

  • Treatment durations usually last between 7 to 10 days, giving the immune system time to respond effectively.

Conclusion of Part One

• This section summarizes the basic principles of chemotherapy and how they relate to treating infectious diseases, establishing a foundation for understanding future treatments and strategies in managing infections.